ArticleNature2022
Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
RetractedAbstract readRetracted Publication
In one paragraph
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 33 papers.
0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 57 citations in OpenAlex.
- Systematic benchmarking of ambient RNA decontamination tools to advance precision in single-cell transcriptomic analysis.Nature communications · 2026Article
- Article
- Single-cell ATAC-seq analysis of human embryoid bodies reveals crucial transcription factor networks involved in early germ layer specification.Cell & bioscience · 2026Article
- Super-enhancer-driven core transcription factor FOXP1 delays endothelial cell senescence via phase separation-mediated SESN3 activation.Theranostics · 2026Article
- Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.Cell reports. Medicine · 2025Article
- Erythrocyte-microglia crosstalk contributing to sex differences in pediatric brain tumorigenesis.Research square · 2025Article
- Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.Nature communications · 2025Article
- Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1.Neuro-oncology · 2025Article
- BrainSTEM: A single-cell multiresolution fetal brain atlas reveals transcriptomic fidelity of human midbrain cultures.Science advances · 2025Article
- Hierarchical regulation of cerebellar neurogenesis by Sin3A-mediated gene repression.bioRxiv : the preprint server for biology · 2025Article
- Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.Cancer research · 2025Article
- The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma.Cell death and differentiation · 2025Article
- Opposite patterns of association of TWIST1 expression with patient survival in SHH and Group 4 medulloblastoma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025Article
- Machine learning assisted nanobeam X-ray diffraction based analysis on hydride vapor-phase epitaxy GaN.Journal of applied crystallography · 2025Article
- Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization.Neuro-oncology · 2025Article
- GABAergic Influences on Medulloblastoma.Brain sciences · 2025Review
- Article
- DNA methylation confers a cerebellum-specific identity in non-human primates.Zoological research · 2025Article
- Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation.Frontiers in oncology · 2025Review
- High Expression of GABABrain sciences · 2024Article
Corrections and comments
- Retraction · 2025-07-09Concerns/Issues about Data · Investigation by Journal/Publisher · Investigation by Third Party · Objections by Author(s) · Unreliable Results and/or Conclusions · · see also: https://www.nature.com/articles/s41586-025-09247-w; see also: https://www.thetransmitter.org/cell-types/nature-retracts-paper-on-novel-brain-cell-type-against-authors-wishes/
- Commented on by
- Retracted
Authors and funding
36 authors at 8 institutions in 4 countries.
Zaili Luo *Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-8773-604X
Mingyang Xia *Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China.
Wei Shi *Department of Neurosurgery, Children's Hospital of Fudan University, Shanghai, China.
Chuntao Zhao *Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Jiajia Wang *Department of Pediatric Neurosurgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dazhuan XinBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Xinran DongKey Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China.
Yu XiongObstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Feng ZhangBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Kalen BerryBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Sean OgurekBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Xuezhao LiuBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Rohit RaoBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Rui XingBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Lai Man Natalie WuBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Siying CuiKey Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China.
Lingli XuKey Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China.
Yifeng LinKey Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China.
Wenkun MaDepartment of Pediatric Neurosurgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shuaiwei TianDepartment of Pediatric Neurosurgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qi XieSchool of Life Sciences, Westlake University, Hangzhou, China.
Li ZhangBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Mei XinBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-5732-7501
Xiaotao WangDepartment of Biochemistry and Molecular Genetics, Feinberg School of Medicine Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-3531-2157
Feng YueDepartment of Biochemistry and Molecular Genetics, Feinberg School of Medicine Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-7954-5462
Haizi ZhengBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Yaping LiuBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Charles B StevensonBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Peter de BlankBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0001-6623-3040
John P PerentesisBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Richard J GilbertsonCancer Research UK Cambridge Centre, CRUK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.ORCID http://orcid.org/0000-0001-7539-9472
Hao LiDepartment of Neurosurgery, Children's Hospital of Fudan University, Shanghai, China. lihao7272@163.com.ORCID http://orcid.org/0000-0001-7755-1749
Jie MaDepartment of Pediatric Neurosurgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. majie@xinhuamed.com.cn.ORCID http://orcid.org/0000-0003-3776-4429
Wenhao ZhouKey Laboratory of Birth Defects, Children's Hospital of Fudan University, Fudan University, Shanghai, China. zhouwenhao@fudan.edu.cn.ORCID http://orcid.org/0000-0001-8956-7238
Michael D TaylorDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-7009-3466
Q Richard LuBrain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lu@cchmc.org.ORCID http://orcid.org/0000-0001-6846-9014
Cincinnati Children's Hospital Medical Center · USChildren's Hospital of Fudan University · CNShanghai Jiao Tong University · CNNorthwestern University · USCancer Research UK Cambridge Center · GBHospital for Sick Children · CAState Key Laboratory of Oncogene and Related Genes · CNWestlake University · CN
Funding
The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0MCancer Research UK 22492Cancer Research UK 26398Cancer Research UK 28598NCI NIH HHS P01 CA096832
Abstract
Medulloblastoma (MB) is the most common malignant childhood brain tumour
Indexed as
Brain NeoplasmsCell Transformation, NeoplasticFetusMedulloblastomaCerebellar NeoplasmsCerebellumHeterogeneous-Nuclear RibonucleoproteinsHumansNeural Stem CellsPrognosisSOXC Transcription FactorsHeterogeneous-Nuclear RibonucleoproteinsHNRNPH1 protein, humanSOX11 protein, humanSOXC Transcription Factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.